Molecular formula: | C33H33N9O2 |
Average mass: | 587.688 |
Monoisotopic mass: | 587.275721 |
ChemSpider ID: | 23078369 |
1 of 1 defined stereocentres
(3R)-1-(2-Oxo-2-{4-[4-(2-pyrimidinyl)phenyl]-1-piperazinyl}ethyl)-N-[3-(4-pyridinyl)-1H-indazol-5-yl]-3-pyrrolidincarboxamid
[German]
[ACD/IUPAC Name](3R)-1-(2-Oxo-2-{4-[4-(2-pyrimidinyl)phenyl]-1-piperazinyl}ethyl)-N-[3-(4-pyridinyl)-1H-indazol-5-yl]-3-pyrrolidinecarboxamide
[ACD/IUPAC Name](3R)-1-(2-Oxo-2-{4-[4-(2-pyrimidinyl)phényl]-1-pipérazinyl}éthyl)-N-[3-(4-pyridinyl)-1H-indazol-5-yl]-3-pyrrolidinecarboxamide
[French]
[ACD/IUPAC Name](3R)-1-(2-Oxo-2-{4-[4-(pyrimidin-2-yl)phenyl]piperazin-1-yl}ethyl)-N-[3-(pyridin-4-yl)-1H-indazol-5-yl]pyrrolidin-3-carboxamid
(3R)-1-(2-oxo-2-{4-[4-(pyrimidin-2-yl)phenyl]piperazin-1-yl}ethyl)-N-[3-(pyridin-4-yl)-1H-indazol-5-yl]pyrrolidine-3-carboxamide
3-Pyrrolidinecarboxamide, 1-[2-oxo-2-[4-[4-(2-pyrimidinyl)phenyl]-1-piperazinyl]ethyl]-N-[3-(4-pyridinyl)-1H-indazol-5-yl]-, (3R)-
[ACD/Index Name]942183-80-4
[RN](3r)-1-(2-Oxo-2-{4-[4-(Pyrimidin-2-Yl)phenyl]piperazin-1-Yl}ethyl)-N-[3-(Pyridin-4-Yl)-2h-Indazol-5-Yl]pyrrolidine-3-Carboxamide
(3R)-1-[2-oxo-2-[4-(4-pyrimidin-2-ylphenyl)piperazin-1-yl]ethyl]-N-(3-pyridin-4-yl-1H-indazol-5-yl)pyrrolidine-3-carboxamide
(3R)-1-[2-oxo-2-[4-[4-(2-pyrimidinyl)phenyl]-1-piperazinyl]ethyl]-N-[3-(4-pyridinyl)-1H-indazol-5-yl]-3-pyrrolidinecarboxamide
(R)-1-(2-oxo-2-(4-(4-(pyrimidin-2-yl)phenyl)piperazin-1-yl)ethyl)-N-(3-(pyridin-4-yl)-1H-indazol-5-yl)pyrrolidine-3-carboxamide
38Z
95%
MFCD11878503
[MDL number]MFCD28144700
[MDL number]Mitogen-activated protein kinase 1
Mitogen-activated protein kinase 3
Mitogen-activated protein kinase 6
MK01_HUMAN
MK03_HUMAN
MK06_HUMAN
MP2K2_HUMAN
SCH 772984;SCH-772984
US8546404, 1730